If I were running Merck I would review ASCO updates to see if there are other complementary immune therapies for Keytruda Then make an offer for IMM before approval looks imminent
It won’t get a lot cheaper
- Forums
- ASX - By Stock
- IMM
- Merck conundrum
IMM
immutep limited
Add to My Watchlist
1.02%
!
24.8¢

Merck conundrum, page-57
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.8¢ |
Change
0.003(1.02%) |
Mkt cap ! $365.0M |
Open | High | Low | Value | Volume |
25.0¢ | 25.3¢ | 24.5¢ | $609.0K | 2.466M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 204342 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 99367 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 204896 | 0.245 |
25 | 514586 | 0.240 |
9 | 436987 | 0.235 |
17 | 370894 | 0.230 |
13 | 496066 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 99579 | 24 |
0.255 | 329027 | 10 |
0.260 | 782776 | 9 |
0.265 | 112843 | 4 |
0.270 | 41600 | 3 |
Last trade - 15.54pm 17/06/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online